News

Los Angeles-Chronic progressive optic neuritis or optic nerve sheath meningioma? Until fairly recently, differentiating these two clinical entities would not have affected the clinical outcome because of the lack of an established safe, efficacious treatment for either condition. However, things have changed, said Howard R. Krauss, MD.

George A. (Jack) Cioffi, MD, is board-certified in ophthalmology. He earned his medical degree from the University of South Carolina and completed his residency in ophthalmology at the University of Maryland and fellowship inresearch and clinical glaucomaat Devers Eye Institute.

New York-Members of the FDA's advisory committee reviewing pegaptanib sodium injection (Macugen) for the treatment of neovascular age-related macular degeneration say they are "impressed" with the drug but declined to take a formal vote.

San Diego-An implantable miniature telescope in the capsular bag provides a permanent visual prosthetic device for patients who are legally blind from bilateral age-related macular degeneration (AMD). While there is a learning curve, an early assessment of the implantation indicates that anterior segment surgeons are familiar with the standard phacoemulsification and manual extracapsular surgical skills used for this procedure, according to David F. Chang, MD.

San Diego-With the availability of foldable IOLs able to correct up to -31 D of spherical error, refractive lens exchange (RLE) for high myopia is now an option for patients hoping to achieve a good refractive outcome. However, patients will need to be monitored long term for potential complications, such as retinal detachments and posterior capsular opacification (PCO), explained Thomas Kohnen, MD, who spoke during the American Society of Cataract and Refractive Surgery annual meeting.

San Diego-Conductive keratoplasty (CK) is proving to be a versatile procedure that also can be used as an off-label procedure to enhance the vision of patients who have undergone cataract extraction. The visual results were excellent and patients expressed satisfaction. CK may be a more attractive procedure for this patient group because of safety and economic considerations, according to Louis D. "Skip" Nichamin, MD.

The only constant in the relatively young life of refractive surgery has been change. Even now as our patients reap the rewards of decades of research in the form of customized wavefront ablation, currently unforeseen improvements are inevitable.

San Diego-There is a great variety of instruments and displays commercially available to assess corneal topography. The array of instrumentation makes it increasingly difficult to interpret corneal topography maps correctly. During the Innovator's Session of the recent annual meeting of the American Society of Cataract and Refractive Surgery, Stephen D. Klyce, PhD, introduced a device-independent neural network-based tool that automatically interprets corneal topography maps.

Portland, OR-Seronegative spondyloarthropathies are the most likely group of diseases that ophthalmologists will encounter in their practices, yet many cases will be overlooked if doctors rely on classic textbook definitions of symptoms, according to James T. Rosenbaum, MD, professor of ophthalmology and medicine, Casey Eye Institute, Oregon Health and Science University, Portland.

Gamagori, Japan-Nidek Co. marked a major milestone with the Aug. 6 shipment of its 1,000th EC-5000 CXII excimer laser system.It was destined for service in the Lin Yi Peoples Hospital in the Shan Tong Province in China.

Vancouver, British Columbia-A research chemist from QLT Inc. who helped develop the verteporfin for injection (Visudyne, QLT/Novartis Ophthalmics) treatment for age-related macular degeneration is among 13 chemists from four companies who have been named Heroes of Chemistry by the American Chemical Society.

Washington, DC-The National Committee for Quality Assurance (NCQA) has approved a glaucoma screening for older adults as part of its 2005 Health Plan Employer Data and Information Set (HEDIS) measures.

Fort Lauderdale, FL-Intravenous squalamine lactate being developed by Geneara Corp. shows promise as a safe and effective treatment for choroidal neovascularization (CNV) associated with age-related macular degeneration (AMD), according toresults of a phase I/II trial presented by Charles A. Garcia, MD, at the annual meeting of the Association for Research in Vision and Ophthalmology.

Lightning Strike

A deafening roar filled the St. Pete Times Forum as a maniac crowdof more than 22,000 people roseto their feet. It was official-the Tampa Bay Lightning had won the 2004 Stanley Cup Championship. Known as "the cut man," Charles B. Slonim, MD, oculoplastic surgeon, stood proud knowing that he was able to assist the winning team medically and surgically.

Lightning Strike

A deafening roar filled the St. Pete Times Forum as a maniac crowdof more than 22,000 people roseto their feet. It was official-the Tampa Bay Lightning had won the 2004 Stanley Cup Championship. Known as "the cut man," Charles B. Slonim, MD, oculoplastic surgeon, stood proud knowing that he was able to assist the winning team medically and surgically.